IMMUNOPROPHYLAXIS OF SEVERE RESPIRATORY-SYNCYTIAL VIRAL INFECTION IN CHILDREN WITH BRONCHOPULMONARY DYSPLASIA: RESULTS OF 4 EPIDEMIC SEASONS

Children with bronchopulmonary dysplasia belong to the risk group of severe respiratory-syncytial viral infection (RSV). World experience and authors' own clinical data show that seasonal immunoprophylaxis of RSV infection's severe course by palivizumab in these patients allows reducing frequency of...

Whakaahuatanga katoa

I tiakina i:

Ngā taipitopito rārangi puna kōrero
Ngā kaituhi matua:	A. A. Baranov, I. V. Davydova, T. V. Turti, L. S. Namazova-Baranova, V. V. Altunin, E. P. Zimina, E. V. Pavlyukova
Hōputu:	Artigo
Reo:	Russo
I whakaputaina:	Union of pediatricians of Russia 2012-12-01
Rangatū:	Педиатрическая фармакология
Ngā marau:	respiratory-syncytial virus bronchopulmonary dysplasia acute respiratory viral infection respiratory function palivizumab
Urunga tuihono:	https://www.pedpharma.ru/jour/article/view/268
Ngā Tūtohu:	Tāpirihia he Tūtohu Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!

IMMUNOPROPHYLAXIS OF SEVERE RESPIRATORY-SYNCYTIAL VIRAL INFECTION IN CHILDREN WITH BRONCHOPULMONARY DYSPLASIA: RESULTS OF 4 EPIDEMIC SEASONS

Ngā tūemi rite